ApiFix announces new leadership

Editor’s note: News about ApiFix management appeared in OrthoSpineNews.

ApiFix ratchet system for scoliosis treatment

The minimally invasive non-fusion system for the treatment of adolescent scoliosis significantly reduces procedure — and recovery — times.

ApiFix, developers of a minimally invasive non-fusion scoliosis correction system, announced the appointment of Ed Roschak, the former CEO of Ellipse Technologies, as its new chairman. Industry veteran Paul Mraz joins him as company president and CEO.

Ed Roschak served as president and CEO of Ellipse Technologies for five years, when it was acquired by NuVasive, Inc. for US$410 million. Ellipse developed a magnetic growth rod technology for treating early onset scoliosis of the spine and for limb lengthening procedures.

Paul Mraz brings more than 25 years of spine and orthopedic medical device experience to ApiFix. He served as CEO and in other senior executive and management positions in U.S.- and Israel-based companies. Previously, he was managing partner of business strategy and leadership consulting firm OnPoint Advisors, which he founded in 2013. From 2006 to 2013, Mraz served as president and CEO of medical device and biologics company Cerapedics, which developed and is now commercializing biologic bone grafting products for the spine and orthopedic markets.

Todd Dollinger, CEO and chairman of Trendlines and outgoing ApiFix chairman, commented, “We believe the deep experiences Ed and Paul bring make them ideal to take ApiFix to the next level, and we are excited to welcome them on board. Trendlines is extremely proud of ApiFix’s achievements to date and we’re confident that the combined efforts of Ed and Paul will be instrumental in realizing ApiFix’s strategic focus on the U.S. and European markets as the company finalizes its application for FDA clearance.”

Dollinger cited Roschak’s substantial work in every aspect of building a scoliosis treatment company as key reasons ApiFix sought to bring him in as chairman of the ApiFix board. Similarly, Mraz has extensive leadership experience bringing innovative spine technologies to market for the benefit of patients and all stakeholders. With ApiFix’s U.S. market entry plans in process, the new CEO will establish ApiFix’s U.S. headquarters in the Boston area. R&D and manufacturing activities will remain in Israel under the leadership of Uri Arnin, ApiFix co-founder and CTO. See the press release about the ApiFix management changes.

The ApiFix system is a disruptive platform technology with its less invasive, non-fusion scoliosis correction system implanted in a short procedure that maintains spine flexibility and requires a brief recovery period.

Leave a Reply

  • Welcome to Trendlines

    We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >

  • Categories

  • Subscribe to Our Newsletter

  • Stay in Touch

    icon-facebook Like us on Facebook

    icon-Twitter Follow us on Twitter

    icon-Linkedin Connect with us on Linkedin

    YouTube-color See us on YouTube

    flipboard  Read us on Flipboard

    google+_icon Join us on Google+

Font Resize